Economic evaluation of PCSK9 inhibitors inclusion in the list of medicines for outpatient preferential drug provision («23 INNs» list) for secondary prevention of cardiovascular events
P. A. Mukhortova, T. O. Bessonova, R. Teryan, O. Shemyakova, K. Matrenin, A. D. Bagdasarov, N. Musina
{"title":"Economic evaluation of PCSK9 inhibitors inclusion in the list of medicines for outpatient preferential drug provision («23 INNs» list) for secondary prevention of cardiovascular events","authors":"P. A. Mukhortova, T. O. Bessonova, R. Teryan, O. Shemyakova, K. Matrenin, A. D. Bagdasarov, N. Musina","doi":"10.17116/medtech20224404151","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":18386,"journal":{"name":"Medical Technologies. Assessment and Choice (Медицинские технологии. Оценка и выбор)","volume":"75 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Technologies. Assessment and Choice (Медицинские технологии. Оценка и выбор)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17116/medtech20224404151","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}